Western blot analysis showed that the expression of Caspase-3 in the sh-beclin1-BPH-1 group was obviously lower compared to the BPH-1 cell group or sh-RNA-BPH-1 group (both p < 0.01) (Fig. 6). This evidence concerns the gene CASP3 and benign prostatic hyperplasia.